Answer
Women of childbearing potential should use effective contraception during ravulizumab treatment and for 8 months after treatment.
Sources for this answer
- Ultomiris 300 mg/3 mL and 1100 mg/11 mL PLGB 31187/0007Alexion Pharma UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 11Document updated
Sources checked